Stefan Chłopicki
Researcher Next ID · RN-041503
Researcher · Biochemistry, Genetics and Molecular Biology
Krakow, Poland
- Works count
- 501
- Citation count
- 10,396
- H-index
- 51
- i10-index
- 277
Research interests
Publications
New hallmarks of ageing: a 2022 Copenhagen ageing meeting summary
Aging · 2022 · https://doi.org/10.18632/aging.204248
IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT) criteria: guidelines of the EU-CARDIOPROTECTION COST Action
Basic Research in Cardiology · 2021 · https://doi.org/10.1007/s00395-021-00893-5
Revisiting pharmacology of oxidative stress and endothelial dysfunction in cardiovascular disease: Evidence for redox-based therapies
Free Radical Biology and Medicine · 2020 · https://doi.org/10.1016/j.freeradbiomed.2020.02.026
Endothelial GLP-1 (Glucagon-Like Peptide-1) Receptor Mediates Cardiovascular Protection by Liraglutide In Mice With Experimental Arterial Hypertension
Arteriosclerosis Thrombosis and Vascular Biology · 2019 · https://doi.org/10.1161/atv.0000615456.97862.30
Treatments targeting inotropy
European Heart Journal · 2018 · https://doi.org/10.1093/eurheartj/ehy600
Liver sinusoidal endothelial cells (LSECs) function and NAFLD; NO-based therapy targeted to the liver
Pharmacological Reports · 2015 · https://doi.org/10.1016/j.pharep.2015.04.010
1‐Methylnicotinamide (MNA), a primary metabolite of nicotinamide, exerts anti‐thrombotic activity mediated by a cyclooxygenase‐2/prostacyclin pathway
British Journal of Pharmacology · 2007 · https://doi.org/10.1038/sj.bjp.0707383
Effect of curcumin on atherosclerosis in apoE/LDLR-double knockout mice.
PubMed · 2005
Current projects
No projects listed.